MENLO THERAPEUTICS INC's ticker is MNLO and the CUSIP is 586858102. A total of 56 filers reported holding MENLO THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,701,000 | -3.6% | 797,565 | -6.9% | 1.27% | -12.0% |
| Q3 2019 | $3,839,000 | +6.8% | 856,936 | +42.8% | 1.44% | +6.9% |
| Q2 2019 | $3,594,000 | -23.7% | 600,030 | 0.0% | 1.35% | -33.5% |
| Q1 2019 | $4,710,000 | +111.5% | 600,030 | +11.0% | 2.03% | +83.6% |
| Q4 2018 | $2,227,000 | -27.5% | 540,637 | +73.3% | 1.11% | -12.3% |
| Q3 2018 | $3,073,000 | +21.3% | 312,000 | 0.0% | 1.26% | +6.4% |
| Q2 2018 | $2,533,000 | – | 312,000 | – | 1.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 1,461,552 | $11,473,000 | 9.29% |
| Vivo Capital, LLC | 4,011,236 | $31,488,000 | 3.14% |
| DAFNA Capital Management LLC | 600,030 | $4,710,000 | 2.03% |
| GREAT POINT PARTNERS LLC | 2,057,027 | $16,148,000 | 1.60% |
| MANGROVE PARTNERS IM, LLC | 561,138 | $4,405,000 | 0.59% |
| Alambic Investment Management, L.P. | 66,996 | $526,000 | 0.22% |
| FIRST MANHATTAN CO. LLC. | 2,256,903 | $17,716,000 | 0.10% |
| Orbimed Advisors | 633,920 | $4,976,000 | 0.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 198,451 | $1,558,000 | 0.06% |
| Baker Brothers Advisors | 700,000 | $5,495,000 | 0.04% |